NCT07110714 Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients
| NCT ID | NCT07110714 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eggensberger OHG |
| Condition | Post COVID-19 Condition |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-12-01 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled study evaluates the effects of cold water hydrotherapy in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to an usual care setting without hydrotherapy treatment.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Post-COVID Syndrome (ICD-10 code: U08.9) * Barthel-Index \>80 * Owning a smartphone to receive digital questionnaires and to use the measurement app for heart rate variability * Written informed consent Exclusion Criteria: * Existing contraindications for Kneipp hydrotherapy like severe cardiovascular diseases (e.g., decompensated heart failure, unstable angina pectoris, acute myocardial infarction), severe venous diseases (e.g., acute deep vein thrombosis of the leg), severe neurological diseases (e.g., uncontrolled epilepsy) * Prior regular practice of Kneipp applications
Contact & Investigator
Rembert Koczulla, MD
PRINCIPAL INVESTIGATOR
Schön Klinik Berchtesgadener Land
Frequently Asked Questions
Who can join the NCT07110714 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post COVID-19 Condition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07110714 currently recruiting?
Yes, NCT07110714 is actively recruiting participants. Contact the research team at a.eggensberger@eggensberger.de for enrollment information.
Where is the NCT07110714 trial being conducted?
This trial is being conducted at Füssen, Germany.
Who is sponsoring the NCT07110714 clinical trial?
NCT07110714 is sponsored by Eggensberger OHG. The principal investigator is Rembert Koczulla, MD at Schön Klinik Berchtesgadener Land. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.